Later studies into the consequences of VEGF inhibitor use have shown that, although they can reduce the growth of primary tumours, VEGF inhibitors can concomitantly promote invasiveness and metastasis of tumours.
Os últimos estudos sobre as consecuencias do uso de inhibidores do VEGF indican que, aínda que poden reducir o crecemento de tumores primarios, os inhibidores do VEGF poden á vez promover a invasividade e metástase dos tumores.